J.P. Morgan Remains a Buy on Rocket Pharmaceuticals (RCKT)
J.P. Morgan analyst Eric Joseph maintained a Buy rating on Rocket Pharmaceuticals (RCKT – Research Report) yesterday and set a price ...
precisionmedicineonline2d
Rocket Pharma Starts Rolling BLA Submission for Fanconi Anemia Gene Therapy
RP-L102, which the firm designed to treat a form of disease caused by FANCA mutations, is already under review with the European Medicines Agency.
Le Lézard2d
Rocket Pharmaceuticals to Participate in the UBS Global Healthcare Conference
Rocket Pharmaceuticals, Inc. , a fully integrated, late-stage biotechnology company advancing a sustainable pipeline of genetic therapies for rare disorders with high unmet need, today announced that ...
Positive Outlook for Rocket Pharmaceuticals Amidst Significant Trial Progress and Regulatory Engagement
TD Cowen analyst Tyler Van Buren has maintained their bullish stance on RCKT stock, giving a Buy rating today. Tyler Van Buren has given his ...
Mirae Asset Global Investments Co. Ltd. Increases Stake in Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT)
Mirae Asset Global Investments Co. Ltd. raised its position in Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT – Free Report) by 21.5% during the third quarter, according to its most recent filing with the ...
Pocket Tactics5d
Brawlhalla tier list November 2024
Our Brawlhalla tier list can help you pick your next main and keep up with the ever-changing meta in this popular platform ...